{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:01:35Z","timestamp":1792612895445,"version":"4.5.0"},"reference-count":24,"publisher":"American Society of Hematology","issue":"19","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,11,6]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>IHC is a valuable clinical tool for assessing CD30+ PTCL patients who may respond to CD30-targeting treatment. CD30 mRNA and protein expression are highly correlated.<\/jats:p>","DOI":"10.1182\/blood-2014-07-584953","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T00:56:58Z","timestamp":1410829018000},"page":"2983-2986","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":127,"title":["Immunohistochemistry as a valuable tool to assess CD30 expression in peripheral T-cell lymphomas: high correlation with mRNA levels"],"prefix":"10.1182","volume":"124","author":[{"given":"C\u00e9line","family":"Bossard","sequence":"first","affiliation":[{"name":"Service d\u2019Anatomie et Cytologie Pathologiques, Centre Hospitalier Universitaire, H\u00f4tel Dieu, Nantes, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pamela","family":"Dobay","sequence":"additional","affiliation":[{"name":"Swiss Institute of Bioinformatics, B\u0203timent Genopode, Lausanne, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Parrens","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Pathologie, H\u00f4pital Pessac, Bordeaux, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Lamant","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Pathologie, H\u00f4pital Purpan, Toulouse, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Missiaglia","sequence":"additional","affiliation":[{"name":"Swiss Institute of Bioinformatics, B\u0203timent Genopode, Lausanne, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Haioun","sequence":"additional","affiliation":[{"name":"Unit\u00e9 H\u00e9mopathies Lympho\u00efdes, Groupe Henri Mondor Albert-Chenevier, Assistance Publique \u2013 H\u00f4pitaux de Paris, Cr\u00e9teil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Martin","sequence":"additional","affiliation":[{"name":"Service d\u2019Anatomie et Cytologie Pathologiques, H\u00f4pital Avicenne, Bobigny, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Fabiani","sequence":"additional","affiliation":[{"name":"D\u00e9partement d\u2019Anatomie Pathologique, H\u00f4pital Saint Antoine, Assistance Publique \u2013 H\u00f4pitaux de Paris, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Delarue","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9matologie, H\u00f4pital Necker, Assistance Publique \u2013 H\u00f4pitaux de Paris, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Tournilhac","sequence":"additional","affiliation":[{"name":"Service de Th\u00e9rapie Cellulaire et d\u2019H\u00e9matologie Clinique Adulte, Universit\u00e9 d\u2019Auvergne, Inserm Centre d'Investigation Clinique 501, Centre Hospitalier Universitaire Clermont-Ferrand H\u00f4pital Estaing, Clermont-Ferrand, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Delorenzi","sequence":"additional","affiliation":[{"name":"Swiss Institute of Bioinformatics, B\u0203timent Genopode, Lausanne, Switzerland;"},{"name":"Ludwig Center for Cancer Research, and"},{"name":"Oncology Department, University of Lausanne, Lausanne, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gaulard","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Pathologie, Groupe Henri-Mondor Albert-Chenevier, Assistance Publique \u2013 H\u00f4pitaux de Paris, Cr\u00e9teil, France;"},{"name":"Inserm U955, Cr\u00e9teil, France;"},{"name":"Universit\u00e9 Paris Est, Cr\u00e9teil, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"de Leval","sequence":"additional","affiliation":[{"name":"Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"3","key":"2019111817205326100_B1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0092-8674(92)90180-K","article-title":"Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin\u2019s disease.","volume":"68","author":"D\u00fcrkop","year":"1992","journal-title":"Cell"},{"issue":"1","key":"2019111817205326100_B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V85.1.1.bloodjournal8511","article-title":"CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy.","volume":"85","author":"Falini","year":"1995","journal-title":"Blood"},{"issue":"18","key":"2019111817205326100_B3","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1200\/JCO.2011.38.0410","article-title":"Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin\u2019s lymphoma.","volume":"30","author":"Younes","year":"2012","journal-title":"J Clin Oncol"},{"issue":"18","key":"2019111817205326100_B4","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1200\/JCO.2011.38.0402","article-title":"Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study.","volume":"30","author":"Pro","year":"2012","journal-title":"J Clin Oncol"},{"issue":"21","key":"2019111817205326100_B5","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1182\/blood.V122.21.4386.4386","article-title":"Brentuximab vedotin administered before, during and after multi-agent chemotherapy in patients with newly diagnosed CD30+ mature T- and NK-cell lymphomas.","volume":"122","author":"Fanale","year":"2013","journal-title":"Blood"},{"issue":"20","key":"2019111817205326100_B6","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1182\/blood-2013-12-542142","article-title":"Objective responses in relapsed T-cell lymphomas with single agent brentuximab vedotin.","volume":"123","author":"Horwitz","year":"2014","journal-title":"Blood"},{"issue":"4","key":"2019111817205326100_B7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/106689690401200410","article-title":"Nasal NK\/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities.","volume":"12","author":"Kuo","year":"2004","journal-title":"Int J Surg Pathol"},{"issue":"5","key":"2019111817205326100_B8","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1053\/j.gastro.2007.03.036","article-title":"Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes.","volume":"132","author":"Deleeuw","year":"2007","journal-title":"Gastroenterology"},{"issue":"17","key":"2019111817205326100_B9","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","article-title":"Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project.","volume":"113","author":"Au","year":"2009","journal-title":"Blood"},{"issue":"3","key":"2019111817205326100_B10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2559.2011.03768.x","article-title":"Pathological and immunohistological findings and genetic aberrations of intestinal enteropathy-associated T cell lymphoma in Japan.","volume":"58","author":"Takeshita","year":"2011","journal-title":"Histopathology"},{"issue":"1","key":"2019111817205326100_B11","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/blood-2011-02-335216","article-title":"Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project.","volume":"118","author":"Delabie","year":"2011","journal-title":"Blood"},{"key":"2019111817205326100_B12","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1182\/blood.V120.21.2706.2706","article-title":"CD30 is a potential therapeutic target in patients with HTLV-1 associated adult T-cell leukemia\/lymphoma presenting outside of Japan [abstract].","volume":"120","author":"Lunning","year":"2012","journal-title":"Blood"},{"issue":"16","key":"2019111817205326100_B13","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","article-title":"Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score.","volume":"24","author":"Went","year":"2006","journal-title":"J Clin Oncol"},{"issue":"2s","key":"2019111817205326100_B14","first-page":"343A","article-title":"Clinicopathologic features of anaplastic large cell lymphoma (ALCL), ALK- and CD30+ peripheral T-cell lymphoma, not otherwise specified (PTCL, nos): a study from the North American T-Cell Lymphoma Consortium.","volume":"26","author":"Macon","year":"2013","journal-title":"Mod Pathol"},{"issue":"12","key":"2019111817205326100_B15","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","article-title":"ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.","volume":"111","author":"Savage","year":"2008","journal-title":"Blood"},{"issue":"8","key":"2019111817205326100_B16","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.3324\/haematol.2013.084913","article-title":"CD30 expression in peripheral T-cell lymphomas.","volume":"98","author":"Sabattini","year":"2013","journal-title":"Haematologica"},{"issue":"11","key":"2019111817205326100_B17","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","article-title":"The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells.","volume":"109","author":"de Leval","year":"2007","journal-title":"Blood"},{"issue":"6","key":"2019111817205326100_B18","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood-2009-05-221275","article-title":"Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK\/T-cell lymphoma, nasal type.","volume":"115","author":"Huang","year":"2010","journal-title":"Blood"},{"issue":"24","key":"2019111817205326100_B19","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1182\/blood-2011-12-396150","article-title":"Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets.","volume":"119","author":"Travert","year":"2012","journal-title":"Blood"},{"key":"2019111817205326100_B20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4137\/CIN.S2846","article-title":"The bimodality index: a criterion for discovering and ranking bimodal signatures from cancer gene expression profiling data.","volume":"7","author":"Wang","year":"2009","journal-title":"Cancer Inform"},{"key":"2019111817205326100_B21","author":"Ohshima"},{"key":"2019111817205326100_B22","author":"Delsol"},{"issue":"21","key":"2019111817205326100_B23","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.V122.21.848.848","article-title":"A phase 2 study of brentuximab vedotin in patients with relapsed or refractory CD30-positive non-Hodgkin lymphomas: interim results in patients with DLBCL and other B-cell lymphomas.","volume":"122","author":"Bartlett","year":"2013","journal-title":"Blood"},{"issue":"4","key":"2019111817205326100_B24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/2040620712443076","article-title":"Safety and efficacy of brentuximab vedotin in patients with Hodgkin lymphoma or systemic anaplastic large cell lymphoma.","volume":"3","author":"Vaklavas","year":"2012","journal-title":"Ther Adv Hematol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/124\/19\/2983\/1380977\/2983.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/124\/19\/2983\/1380977\/2983.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T17:21:04Z","timestamp":1574097664000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/124\/19\/2983\/33276\/Immunohistochemistry-as-a-valuable-tool-to-assess"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,6]]},"references-count":24,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2014,11,6]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2014-07-584953","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,6]]}}}